The U.S. FDA amended the terms of its emergency use authorizations for the Pfizer and Moderna bivalent vaccines, allowing people ages 65 and older and immunocompromised people to get additional doses before this fall’s vaccination campaigns.
Namely, adults ages 65 and older who have received a single dose of a bivalent vaccine may receive an additional dose at least four months following their first dose.
“My only question is why the 65 year age cutoff? What was that based on? Ordinarily I would have preferred that it be brought down to 60 or even 50,” Hotez said in an email to CNN. Another big change is that most unvaccinated individuals may now receive a single dose of a bivalent vaccine, rather than multiple doses of the original single-strain vaccines, the agency said. The FDA simplified its recommendation for unvaccinated individuals after recognizing that most Americans now have some immunity against COVID-19, even if “ts just through past infections.
The agency stressed that most people who have gotten one dose of a bivalent vaccine are not currently eligible for a second dose. But the agency has not been free to make what's known as a “permissive use” recommendation about the boosters, which would allow doctors to offer additional doses to vulnerable patients because of the terms of the EUA.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA clears the way for additional bivalent boosters for certain vulnerable individuals | CNNThe U.S. Food and Drug Administration amended the terms of its emergency use authorizations for the Pfizer and Moderna bivalent vaccines on Tuesday, allowing people ages 65 and older and certain people with weakened immunity to get additional doses before this fall's vaccination campaigns.
Weiterlesen »
FDA clears second bivalent COVID boosters for some AmericansSome Americans will soon be able to get another shot of the bivalent COVID-19 vaccines, the FDA authorized Tuesday, including seniors ages 65 and older and people with compromised immune systems.
Weiterlesen »
FDA authorizes additional omicron Covid shots for seniors and people with weak immune systemsAlthough the burden of the pandemic has eased substantially, the CDC says Covid continues to kill more than 1,300 people per week.
Weiterlesen »
FDA simplifies COVID vaccine schedules, withdraws authorization for older COVID-19 vaccines targeting virus' original strainThe FDA is authorizing a second omicron-targeted bivalent COVID-19 booster vaccine for people over 65 or who are immunocompromised, the agency announces.
Weiterlesen »
FDA okays second omicron booster for people at high risk from covidBreaking news: FDA clears a second omicron-targeting booster shot for people who are at high risk from the coronavirus
Weiterlesen »
FDA authorizes second bivalent COVID booster for older adultsThe U.S. Food and Drug Administration on Tuesday authorized a second dose of Omicron-targeting COVID-19 vaccines for older adults as well as those with a weak immune system.
Weiterlesen »